about
The interaction of force and repetition on musculoskeletal and neural tissue responses and sensorimotor behavior in a rat model of work-related musculoskeletal disordersProgrammed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta roleMedical Therapy of Fibrostenotic Crohn's DiseaseRole of endoglin in fibrosis and sclerodermaThe role of the myofibroblast in tumor stroma remodelingGene expression signature of DMBA-induced hamster buccal pouch carcinomas: modulation by chlorophyllin and ellagic acidTGF-β signaling and its targeting for glioma treatmentEpithelial-mesenchymal transition: An emerging target in tissue fibrosisIncreased serum and musculotendinous fibrogenic proteins following persistent low-grade inflammation in a rat model of long-term upper extremity overuseIncreased CCN2, substance P and tissue fibrosis are associated with sensorimotor declines in a rat model of repetitive overuse injury.Halofuginone inhibits the establishment and progression of melanoma bone metastases.New molecular medicine-based scar management strategiesAntibody therapy can enhance AngiotensinII-induced myocardial fibrosis.An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signalingIntratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic CellsTransforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction.Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle.Leucine supplementation accelerates connective tissue repair of injured tibialis anterior muscleAntifibrotic effects of roscovitine in normal and scleroderma fibroblasts.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Immunomodulatory effects of transforming growth factor-β in the liver.Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis.Differential knockdown of TGF-β ligands in a three-dimensional co-culture tumor- stromal interaction model of lung cancer.Sphingosine kinase inhibitors and cancer: seeking the golden sword of HerculesConnective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signalingTIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.BMP2 signals loss of epithelial character in epicardial cells but requires the Type III TGFβ receptor to promote invasion.Computational Identification of Mechanistic Factors That Determine the Timing and Intensity of the Inflammatory Response.Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease.Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancerIrinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.Isolation of TGF-β-neutralizing single-domain antibodies of predetermined epitope specificity using next-generation DNA sequencing.Fibulin-4 deficiency increases TGF-β signalling in aortic smooth muscle cells due to elevated TGF-β2 levels.Targeting the TGFβ signalling pathway in disease.TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic targetCommon pathways regulate Type III TGFβ receptor-dependent cell invasion in epicardial and endocardial cells.Arkadia regulates tumor metastasis by modulation of the TGF-β pathway.The Lymphatic System in Disease Processes and Cancer ProgressionNeuroinflammatory and autonomic mechanisms in diabetes and hypertension.
P2860
Q21257169-954E8E02-B433-485E-834D-65D232942BEFQ26769734-ADC7A54D-47B7-41E8-B030-AC5441024D12Q26777724-4DBBAD01-D133-4DDF-B37F-87B412F3C33FQ26821836-5DE722FD-2062-491F-83E8-A72AA8F93779Q26997815-811F23BC-992B-4A68-A7DC-10984AEED98DQ27305099-1E41F18E-4412-4B64-BC00-FF0CF0FF27AEQ28082042-7532F11F-07FA-4B8B-9667-DD2737298C1AQ28083351-F8E9AD73-C54C-4AA3-AA8E-93422ED422CBQ28387881-04DDA661-81E8-43E7-AF52-61A177A71BAAQ28392878-99D4FF39-4981-4EAC-9723-4AC4F7F08BA5Q30393926-7DEBD8B7-26DE-47A2-9659-231E6367B538Q33560989-E57142A0-D9C8-473B-B1DB-645E78A2ED35Q33614147-8221CC9C-AC90-402E-BA15-3AC3A428C615Q33615675-77909F60-E607-4B28-A37E-9DE3EF2620BAQ33858506-E9581186-A94D-40BF-9DA6-5720D97EF403Q34089713-167EBCD8-0CF6-401F-9F4D-5B0994F79D96Q34201678-5A146A39-C388-4D06-802D-4D598BB26162Q34411598-BF1AAE15-171B-4645-BCD1-4D99AD188242Q34489708-4273C25D-CF0A-4889-834B-B24DF35DBD65Q34504710-EBA29434-46F5-4A79-9805-BA3962F8A89CQ34750481-FF134C82-BC24-435E-A7BD-4C38AF125593Q35161856-AE848E18-A648-48D0-AA26-460A64C25B43Q35222167-8BA43A49-34B8-47B4-98BA-40948262ACDCQ35501532-021CDC0C-E5A7-457F-ADA7-18148ACE3E5AQ35541207-C46B2025-415C-4CC5-BE2A-1A4824557E6BQ35651935-6A549976-BF30-4B47-9447-2F4503527C95Q35784389-BAB601FB-19C6-4DEE-B759-8D533A1C1BBEQ35859983-92BA4EED-4CDA-4F9B-93EF-4B2787D96698Q35876184-F538A13A-3625-48FC-81AC-AD59E8A5F0CBQ36081416-AD6E295C-7403-4444-A9FC-50DA2199EA45Q36119996-1A67C76F-31BD-4AEE-A93A-5481A1F67240Q36129111-ACA9D193-47F4-4A14-9DA9-976E04152F69Q36320690-F1B07BBA-51DD-4961-A790-65020939A536Q36462348-CF2DEF49-6ED2-42DE-9E23-811EBA4C8098Q36638173-07FF5C29-384B-4FD1-BD88-B151B0CF6D3BQ36673270-FE952F13-00D9-4497-837F-9E46ABEE09D5Q36786619-FA486191-2B8D-4CE1-9397-516F1687EF48Q36903858-2B8AA806-C404-4AF4-BA3D-93F6D4990D1BQ37099065-9415C5EA-30BA-421B-9F8C-9B14917C8BD1Q37139426-CF97BDD3-8FD0-4488-88EF-5FC1231B3BBB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Exploring anti-TGF-β therapies in cancer and fibrosis.
@en
Exploring anti-TGF-β therapies in cancer and fibrosis.
@nl
type
label
Exploring anti-TGF-β therapies in cancer and fibrosis.
@en
Exploring anti-TGF-β therapies in cancer and fibrosis.
@nl
prefLabel
Exploring anti-TGF-β therapies in cancer and fibrosis.
@en
Exploring anti-TGF-β therapies in cancer and fibrosis.
@nl
P2860
P1476
Exploring anti-TGF-β therapies in cancer and fibrosis
@en
P2093
Peter Ten Dijke
P2860
P304
P356
10.3109/08977194.2011.595411
P577
2011-06-30T00:00:00Z